Biomarkers of (osteo)arthritis.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26954784)

Published in Biomarkers on December 01, 2015

Authors

Ali Mobasheri1,2,3,4, Yves Henrotin5,6

Author Affiliations

1: a Department of Veterinary Pre-Clinical Sciences , School of Veterinary Medicine, University of Surrey , Guildford , UK .
2: b Faculty of Health and Medical Sciences, Duke of Kent Building , University of Surrey , Guildford, Surrey , UK .
3: c Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis, Arthritis Research UK Pain Centre, Medical Research Council and Arthritis Research UK Centre for Musculoskeletal Ageing Research, Queen's Medical Centre , Nottingham , UK .
4: d Center of Excellence in Genomic Medicine Research (CEGMR), King Fahd Medical Research Center (KFMRC), Faculty of Applied Medical Sciences, King Abdulaziz University , Jeddah , Kingdom of Saudi Arabia .
5: e Bone and Cartilage Research Unit, Arthropole Liege, Department of Motricity Sciences , Institute of Pathology, University of Liege , Liege , Belgium , and.
6: f Physical Therapy and Rehabilitation Department , Princess Paola Hospital , Marche-en-Famenne , Belgium.

Articles cited by this

A new initiative on precision medicine. N Engl J Med (2015) 16.03

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther (2001) 14.78

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36

Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36

The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis (2014) 3.48

FRAX and its applications to clinical practice. Bone (2009) 3.32

Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect (1998) 3.27

Identification of a central role for complement in osteoarthritis. Nat Med (2011) 3.11

Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10

Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res (2001) 3.09

Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage (2012) 2.62

Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem (1992) 2.58

The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37

Biological markers in osteoarthritis. Nat Clin Pract Rheumatol (2007) 1.95

Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. Osteoarthritis Cartilage (2010) 1.75

Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage (2012) 1.62

Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis (1994) 1.45

Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet (2001) 1.41

Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis (2013) 1.40

Osteoarthritis year 2012 in review: biomarkers. Osteoarthritis Cartilage (2012) 1.20

Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol (2014) 1.17

Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage (2009) 1.16

Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol (2012) 1.16

The chondrocyte. Int J Biochem Cell Biol (2003) 1.15

Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol (2014) 1.15

Is osteoarthritis a metabolic disease? Joint Bone Spine (2013) 1.13

Diagnosis of osteoarthritis: imaging. Bone (2011) 1.13

Biological markers in osteoarthritis. Bone (2012) 1.08

Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol (2015) 1.02

Aging-related inflammation in osteoarthritis. Osteoarthritis Cartilage (2015) 1.02

Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage (2015) 0.97

Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthritis Cartilage (2016) 0.97

Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study. Ann Rheum Dis (2013) 0.96

The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep (2013) 0.95

Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas (2014) 0.95

The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol (2015) 0.92

The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep (2013) 0.92

Osteoarthritis in 2012: Parallel evolution of OA phenotypes and therapies. Nat Rev Rheumatol (2013) 0.88

Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open (2015) 0.87

Is osteoarthritis a metabolic disorder? Br Med Bull (2015) 0.86

The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. Osteoarthritis Cartilage (2012) 0.86

Leptin in osteoarthritis: Focus on articular cartilage and chondrocytes. Life Sci (2015) 0.85

Physicochemical and biomechanical stimuli in cell-based articular cartilage repair. Curr Rheumatol Rep (2015) 0.84

Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons - a scoping review. Obes Rev (2014) 0.84

Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthritis Cartilage (2013) 0.84

The application of optical coherence tomography in musculoskeletal disease. Arthritis (2013) 0.84

Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage (2015) 0.84

Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis Cartilage (2012) 0.82

Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women. Biomarkers (2016) 0.82

Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers (2016) 0.81

Associations between cardiovascular disease severity, osteoarthritis co-morbidity and physical health: a population-based study. Rheumatology (Oxford) (2014) 0.80

The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers (2015) 0.80

A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data. BMC Genomics (2015) 0.78

Chopping off the chondrocyte proteome. Biomarkers (2014) 0.78

Adipokines as potential prognostic biomarkers in patients with acute knee injury. Biomarkers (2015) 0.77

Detecting early stage osteoarthritis by optical coherence tomography? Biomarkers (2016) 0.76

Applying computation biology and "big data" to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis. Biomarkers (2016) 0.76

Label-free proteomic analysis of the hydrophobic membrane protein complement in articular chondrocytes: a technique for identification of membrane biomarkers. Biomarkers (2016) 0.76

Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine. Biomarkers (2015) 0.76